Illumina and Applera Settle Patent Disputes

Law360, New York (August 20, 2004, 12:00 AM EDT) -- Biotech rivals Illumina, Inc. and Applera Corp. have agreed to settle two lawsuits over a partnership that went sour, penning a deal that involves royalty-free cross-licensing of key technologies and the dismissal of two patent infringement suits.

The settlement includes an exchange of royalty-free cross-licenses to “certain intellectual property rights” and express termination of the joint development agreement, the two companies said in a statement.

As part of the agreement, Applera said it would dismiss a patent infringement action brought against Illumina in the Northern District...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.